Login to Your Account

With $54M Left, Renovo Limps Toward the End

By Nuala Moran

Thursday, June 2, 2011
LONDON – As the process of winding down the company continues, Renovo plc's CEO, Mark Ferguson, estimated there will be $54.3 million left in the coffers once the process is complete, and said the company has decided to see ongoing clinical trials through to a conclusion.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription